Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
relenopride
- Development stage
- Phase 2
- Lead developer
- SK Biopharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Relenopride is a small molecule drug developed as a selective serotonin 4 (5-HT4) receptor agonist, primarily investigated for its prokinetic effects on gastrointestinal motility. It acts by stimulating 5-HT4 receptors in the gut, thereby enhancing colonic and gastric motility and accelerating gastric emptying. Relenopride has been studied in phase II clinical trials for chronic idiopathic constipation, functional constipation, and irritable bowel syndrome (IBS), where it demonstrated efficacy in improving bowel function with a favorable safety profile. More recently, it has also been under investigation for rare neurological disorders. The drug was originally developed by SK Biopharmaceuticals and its affiliate SK Life Science[1][2][3][4][5][6][7].
- Other names
- relenopride hydrochloride
02
Targets
HTR4 (5-Hydroxytryptamine receptor 4)
Beyond the preview
Go deeper on relenopride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on relenopride.